Curtis Lockshin

The Company's principal activity is to seek a new operating business or enter into a merger transaction. Previously the Company provided arbitration and mediation services, also known as alternative dispute resolution services (ADR) and related electronic oversight applications. In addition, the Company offered advisory opinions, mock jury trials and other specialized dispute resolution programs depending on the parties' particular needs. Currently the Company does not operate any business.

The Company intends to open Mother Supercare Centers in target areas across the United States. The Mother Supercare Centers will offer prenatal, childbirth, postpartum and parenting services to women and their families. These services will be provided through education, counseling, support services and products for women and infants that promote a healthy pregnancy, birth, postpartum and early parenting period. The Group is a development Stage Company.

The Company is develops and markets Computere Software.The Company was Founded in 1989 and it's Headquartered is in Miami,FL.

Xenetic Biosciences (UK) Ltd. is engaged in the development of drug and vaccine delivery systems and proprietary products in the fields of protein drugs, vaccines and oncology. It provides specialist delivery solutions to improve the efficacy and performance of drugs and vaccines in a number of key medical areas including oncology. The company's product pipeline includes polyxen, imuxen and oncohist. Xenetic Biosciences was founded by Gregory Gregoriadis on June 24, 1996 and is headquartered in London, the United Kingdom.

Tiger X Medical, Inc. engages in the collection and management of royalty income earned in connection with the Asset Purchase Agreement with Arthrex, Inc. It continue to advance and promote its former knee product lines through participation in mobile teaching labs, seminars, and live surgery. Its also evaluates future investment opportunities and uses for its cash. The company was founded by Andrew A. Brooks on April 6, 2007 and is headquartered in Los Angeles, CA.

Part of Pharmsynthez PJSC, Guardum Pharmaceuticals LLC produces pharmaceutical preparations. The private company is based in Miami, FL. Guardum Pharmaceuticals was acquired by Pharmsynthez PJSC on April 18, 2013.

Part of VBI Vaccines, Inc., SciVac Ltd. is an Israeli company that develops and markets biological products for human healthcare. The private company is based in Rehovot, Israel. SciVac was acquired by Levon Resources Ltd. on July 09, 2015 for $73.16 million.